Server:nginx...
X-Powered-By:PHP/5.6.36, PleskLin
The main IP address: 162.13.135.168,Your server United Kingdom,Eton ISP:Cue Media Solutions Ltd. IP Space TLD:com CountryCode:GB
The description :you are using an outdated browser. please upgrade your browser to improve your experience. contact us search -- about us board members our leadership partners scientific approach gene therapy concept...
This report updates in 30-Jun-2018
Created Date: | 2009-07-26 |
Changed Date: | 2016-07-19 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host threeriverssport.com. Currently, hosted in United Kingdom and its service provider is Cue Media Solutions Ltd. IP Space .
Latitude: | 51.488330841064 |
Longitude: | -0.60904997587204 |
Country: | United Kingdom (GB) |
City: | Eton |
Region: | England |
ISP: | Cue Media Solutions Ltd. IP Space |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.
X-Powered-By: | PHP/5.6.36, PleskLin |
Transfer-Encoding: | chunked |
Set-Cookie: | ci_session=qns8dd5g962ku8opnhpij6dncs52msau; expires=Sat, 30-Jun-2018 13:47:51 GMT; Max-Age=7200; path=/; secure; HttpOnly |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Server: | nginx |
Connection: | keep-alive |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Sat, 30 Jun 2018 11:47:51 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns.rackspace.com. hostmaster.rackspace.com. 1493715505 3600 300 1814400 300 |
ns: | ns.rackspace.com. ns2.rackspace.com. |
ipv4: | IP:162.13.135.168 ASN:15395 OWNER:RACKSPACE-LON, GB Country:GB |
you are using an outdated browser. please upgrade your browser to improve your experience. contact us search -- about us board members our leadership partners scientific approach gene therapy concept wilson's disease faqs wilson's disease resources unmet medical needs potential benefits of aav gene therapy patient & families resources other liver indications investors work at vivet news & events news events research & publications vivet therapeutics fiercebiotech names vivet therapeutics as one of its 2017 'fierce 15' read more transforming lives novel gene therapies for rare, inherited metabolic diseases read more wilson’s disease benefits of aav gene therapy as a novel approach to manage wilson’s disease read more gene therapy programs a dedicated platform for the development of innovative treatments for inherited liver diseases in collaboration with cima based on aav-anc80 from mee product pipeline targeting life threatening and severely debilitating liver metabolic disorders with high unmet medical need in pediatric and adult patients wilson's disease development of a high-activity atp7b transgene paves the way towards restoring normal copper metabolism in wilson’s disease patients through gene therapy welcome to vivet therapeutics vivet therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. vivet therapeutics is focused on optimizing gene therapy through collaborating with the fundacion para la investigacion medica aplicada (fima) at the centro de investigación medica aplicada (cima, universidad de navarra) to develop new aav vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. latest news vivet therapeutics appoints eduardo bravo as new chairman of the board paris, france june 12th, 2018, vivet therapeutics, a biotechnology company developing novel gene therapies for rare, inherited metabolic diseases today… fiercebiotech names vivet therapeutics as one of its 2017 “fierce 15” biotech companies paris, france september 28th, 2017, vivet therapeutics is proud to announce that it has been named by fiercebiotech as one… vivet’s first gene therapy product, vtx 801 for wilson’s disease, receives eu and us odd paris, france september 26th, 2017, vivet therapeutics, announced today that both the food and drug administration (fda) and the european… fda news : cellular & gene therapy guidances a useful resource of cellular & gene therapy guidance documents ema news this section of the website provides information for companies and individuals involved in developing and marketing medicines for human use… gene therapy of liver diseases in europe, a disease is defined as rare when it affects fewer than one out of every 2,000 people. however,… vivet therapeutics raises €37.5 million in series a financing round vivet therapeutics raises €37.5 million in series a financing round to advance novel gene therapies for treating inherited metabolic diseases top sign up to stay in touch submit contact us vivet therapeutics 29 rue tronchet 75008 paris, france [email protected] 01234 567 890 -- our site uses cookies. to find out what cookies we use and why we use them click here . if you carry on using our site we will assume you consent to us using cookies in this way. ') english español français --
https://www.vivet-therapeutics.com/en/en/news-events/latest/ema-news
https://www.vivet-therapeutics.com/en/en/news-events/latest/fda-news
https://www.vivet-therapeutics.com/en/#0
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/other-liver-indications
https://www.vivet-therapeutics.com/en/en/news-events/events
https://www.vivet-therapeutics.com/en/es
https://www.vivet-therapeutics.com/en/en/search
https://www.vivet-therapeutics.com/en/en/news-events/research-publications
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/wilsons-disease-resources/patient-families-resources
https://www.vivet-therapeutics.com/en/en/about-us
https://www.vivet-therapeutics.com/en/en/investors
https://www.vivet-therapeutics.com/en/en/scientific-approach
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/wilsons-disease-faqs
https://www.vivet-therapeutics.com/en/en/news-events/news
https://www.vivet-therapeutics.com/en/en/home
raredesign.co.uk
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: THREERIVERSSPORT.COM
Registry Domain ID: 1563631741_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-07-19T04:40:33Z
Creation Date: 2009-07-26T20:33:08Z
Registry Expiry Date: 2018-07-26T20:33:08Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.RACKSPACE.COM
Name Server: NS2.RACKSPACE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-27T05:36:24Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR 123-Reg Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =threeriverssport.com
PORT 43
TYPE domain
DOMAIN
NAME threeriverssport.com
CHANGED 2016-07-19
CREATED 2009-07-26
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS.RACKSPACE.COM 69.20.95.4
NS2.RACKSPACE.COM 65.61.188.4
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .